Autosomal recessive parkinsonism

Healy, 2008, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study, Lancet Neurol, 7, 583, 10.1016/S1474-4422(08)70117-0

Bonifati, 2007, Genetics of parkinsonism, Parkinsonism Relat Disord, 13, S233, 10.1016/S1353-8020(08)70008-7

Ahlskog, 2009, Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease, Parkinsonism Relat Disord, 15, 721, 10.1016/j.parkreldis.2009.09.010

Bonifati, 2010, PARK7, DJ1, vol. 3, 392

Ramirez, 2006, Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat Genet, 38, 1184, 10.1038/ng1884

Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416

Valente, 2004, Hereditary early-onset Parkinson's disease caused by mutations in PINK1, Science, 304, 1158, 10.1126/science.1096284

Bonifati, 2003, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, 299, 256, 10.1126/science.1077209

Lucking, 2000, Association between early-onset Parkinson's disease and mutations in the parkin gene, N Engl J Med, 342, 1560, 10.1056/NEJM200005253422103

Kumazawa, 2008, Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease, Arch Neurol, 65, 802, 10.1001/archneur.65.6.802

Kay, 2010, A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2, Neurology, 75, 1189, 10.1212/WNL.0b013e3181f4d832

Samaranch, 2010, PINK1-linked parkinsonism is associated with Lewy body pathology, Brain, 133, 1128, 10.1093/brain/awq051

Lohmann, 2003, How much phenotypic variation can be attributed to parkin genotype?, Ann Neurol, 54, 176, 10.1002/ana.10613

Shin, 2011, PARIS (ZNF746) repression of PGC-lalpha contributes to neurodegeneration in Parkinson's disease, Cell, 144, 689, 10.1016/j.cell.2011.02.010

Narendra, 2010, PINK1 is selectively stabilized on impaired mitochondria to activate Parkin, PLoS Biol, 8, e1000298, 10.1371/journal.pbio.1000298

Crosiers, 2011, Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation, Parkinsonism Relat Disord, 17, 135, 10.1016/j.parkreldis.2010.10.011

Santoro, 2011, Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability, Neurogenetics, 12, 33, 10.1007/s10048-010-0259-0

Li, 2011, A new perspective in Parkinson's disease, chaperone-mediated autophagy, Parkinsonism Relat Disord, 17, 231, 10.1016/j.parkreldis.2010.12.008

Nishioka, 2011, Glucocerebrosidase mutations in diffuse Lewy body disease, Parkinsonism Relat Disord, 17, 55, 10.1016/j.parkreldis.2010.09.009

Paisan-Ruiz, 2009, Characterization of PLA2G6 as a locus for dystonia-parkinsonism, Ann Neurol, 65, 19, 10.1002/ana.21415

Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2010 Jul 20 [Epub ahead of print]. doi: 10.1016/j.neurobiolaging.2010.05.009.

Di Fonzo, 2009, FBXO7 mutations cause autosomal recessive, early-onset parkinsonianpyramidal syndrome, Neurology, 72, 240, 10.1212/01.wnl.0000338144.10967.2b

Zhao, 2011, Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15), PLoS One, 6, e16983, 10.1371/journal.pone.0016983